NCT04993066View on ClinicalTrials.gov

Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

November 12, 2020

Primary Completion Date

May 31, 2022

Study Completion Date

April 27, 2023

Conditions
Pseudofolliculitis BarbaeUnwanted HairPigmented LesionsVascular LesionOnychomycosisWrinkleAcne
Interventions
DEVICE

GentleMax Pro Plus

The GentleMax Pro Plus laser system to be used in this study received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) under K201111 on May 26, 2020

Trial Locations (1)

01752

Candela Institute of Excellence, Marlborough

Sponsors
All Listed Sponsors
lead

Candela Corporation

INDUSTRY